PT2968420T - Utilização de células estaminais placentárias no tratamento de lesão renal aguda - Google Patents

Utilização de células estaminais placentárias no tratamento de lesão renal aguda

Info

Publication number
PT2968420T
PT2968420T PT14775592T PT14775592T PT2968420T PT 2968420 T PT2968420 T PT 2968420T PT 14775592 T PT14775592 T PT 14775592T PT 14775592 T PT14775592 T PT 14775592T PT 2968420 T PT2968420 T PT 2968420T
Authority
PT
Portugal
Prior art keywords
treatment
stem cells
placental stem
kidney injury
acute kidney
Prior art date
Application number
PT14775592T
Other languages
English (en)
Inventor
A Fischkoff Steven
Chen Hong-Jung
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of PT2968420T publication Critical patent/PT2968420T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PT14775592T 2013-03-14 2014-03-13 Utilização de células estaminais placentárias no tratamento de lesão renal aguda PT2968420T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361785252P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
PT2968420T true PT2968420T (pt) 2019-01-11

Family

ID=51625261

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14775592T PT2968420T (pt) 2013-03-14 2014-03-13 Utilização de células estaminais placentárias no tratamento de lesão renal aguda

Country Status (9)

Country Link
US (2) US20160030488A1 (pt)
EP (1) EP2968420B1 (pt)
JP (4) JP2016512555A (pt)
DK (1) DK2968420T3 (pt)
ES (1) ES2703784T3 (pt)
HK (1) HK1220135A1 (pt)
PL (1) PL2968420T3 (pt)
PT (1) PT2968420T (pt)
WO (1) WO2014159826A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3548051A1 (en) * 2016-12-05 2019-10-09 Celularity, Inc. Treatment of lymphedema and related conditions using placental adherent cells
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA2476553A1 (en) * 2002-02-13 2003-08-21 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
KR20180105266A (ko) * 2005-12-29 2018-09-27 안트로제네시스 코포레이션 태반 줄기 세포 집단
EP2120977B1 (en) * 2007-02-12 2013-05-15 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
CA2701435C (en) * 2007-10-05 2017-06-20 Ethicon, Inc. Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
WO2009114826A2 (en) * 2008-03-13 2009-09-17 Angiodynamics, Inc. Treatment systems and methods for renal-related diseases
NZ602808A (en) * 2010-04-07 2014-10-31 Anthrogenesis Corp Angiogenesis using placental stem cells
WO2011127113A1 (en) * 2010-04-08 2011-10-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
CA2841713A1 (en) * 2011-07-15 2013-01-24 Anthrogenesis Corporation Treatment of radiation injury using amnion derived adherent cells

Also Published As

Publication number Publication date
EP2968420A4 (en) 2016-11-23
WO2014159826A1 (en) 2014-10-02
ES2703784T3 (es) 2019-03-12
JP2023022018A (ja) 2023-02-14
JP2019055955A (ja) 2019-04-11
US20190388478A1 (en) 2019-12-26
US11696930B2 (en) 2023-07-11
HK1220135A1 (zh) 2017-04-28
DK2968420T3 (da) 2019-01-02
JP2021038229A (ja) 2021-03-11
US20160030488A1 (en) 2016-02-04
PL2968420T3 (pl) 2019-08-30
EP2968420B1 (en) 2018-09-05
EP2968420A1 (en) 2016-01-20
JP2016512555A (ja) 2016-04-28

Similar Documents

Publication Publication Date Title
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
IL246239B (en) Bicyclic heterocyclic compounds and their uses in healing
HK1222552A1 (zh) 索布替羅用於治療髓鞘形成疾病
GB2509710B (en) Photobioreactor and its use in waste water treatment
HUE047062T2 (hu) Angiotenzin II alacsony vérnyomás kombinációs kezelésére
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
HK1220135A1 (zh) 胎盤幹細胞治療急性腎損傷的用途
EP2964227A4 (en) TREATMENT AND PROPHYLAXIS OF RENAL DISEASES
GB201302839D0 (en) Water Treatment
HK1209033A1 (zh) 奧地帕西在治療黏多醣症病中的應用
ZA201604412B (en) Water treatment
HK1209097A1 (en) Water treatment
EP2970883A4 (en) IMPROVED PLACENTAL STEM CELLS AND USES THEREOF
GB201304038D0 (en) Treated cells and therapeutic uses
GB201416965D0 (en) Water treatment
EP3104863C0 (en) SALICYLATE FOR USE IN THE TREATMENT OF CANCER
ZA201406350B (en) Water treatment
GB201322755D0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201315704D0 (en) Water treatment
GB201314731D0 (en) Water treatment